Systane Clinical Experience Study

Dry Eye Syndrome Clinical Trial

Official title:

Study to Evaluate the Physical Effect of SYSTANE QID in People That Have Moderate to Severe Dry Feeling Eyes

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00818909
• Other study ID #: CARES-3
• Status: Completed
• Phase: Phase 4
• First received: January 7, 2009
• Last updated: January 31, 2012
• Start date: January 2009
• Est. completion date: October 2009

Study information

• Verified date: January 2012
• Source: Alcon Research
• Contact: n/a
• Is FDA regulated: No
• Health authority: Taiwan: Institutional Review Board
• Study type: Interventional

Clinical Trial Summary

To evaluate the physical effect of SYSTANE QID in people that have moderate to severe dry eyes and to establish doctor confidence to prescribe Systane.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 941
• Est. completion date: October 2009
• Est. primary completion date: October 2009
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• moderate to severe dry feeling eyes

Exclusion Criteria:

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Dry Eye Syndrome
• Dry Eye Syndromes
• Keratoconjunctivitis Sicca

Intervention

Other:
• Systane
Systane prescription

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Alcon Research

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	corneal and conjunctiva staining score		4 weeks	No
Secondary	Tear film break up time		4 weeks	No